It might start with a shortness of breath that’s easily dismissed as getting older or needing more exercise. But for the nearly 3 million patients with idiopathic pulmonary fibrosis (IPF), this subtle symptom rapidly worsens into a suffocating inability to breathe, often leading to a dangerous elevation in pulmonary artery pressure, related heart attacks or…Continue Reading USC physician-scientists Denis Evseenko and Toby Maher win $3.2 million grant from the National Institute on Aging to develop regenerative drug for idiopathic pulmonary fibrosis
